Drospiren-Eth estra-Levomefol Ca 3-0.03-0.451 MG (21) Oral Tablet / Levomefol Ca 0.451 MG (7) Oral Tablet 28 Day Pack
- RxCUI
- 1050493
- RxNorm name
- Drospiren-Eth estra-Levomefol Ca 3-0.03-0.451 MG (21) Oral Tablet / Levomefol Ca 0.451 MG (7) Oral Tablet 28 Day Pack
- Display name
- Drospiren-Eth estra-Levomefol Ca 3-0.03-0.451 MG (21) Oral Tablet / Levomefol Ca 0.451 MG (7) Oral Tablet 28 Day Pack
- Full name
- Drospiren-Eth estra-Levomefol Ca 3-0.03-0.451 MG (21) Oral Tablet / Levomefol Ca 0.451 MG (7) Oral Tablet 28 Day Pack
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:09
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium | DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM | Sandoz Inc | 6928f186-190d-4c40-beab-81cf80cd45cb | 2026-03-04 | Boxed warning, Warnings, Adverse reactions | 1050493 |
| Safyral | DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM | Bayer HealthCare Pharmaceuticals Inc. | 97563516-306a-4e17-9690-edbda49ecd83 | 2026-03-04 | Boxed warning, Warnings, Adverse reactions | 1050493 |
| Tydemy | DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM | Lupin Pharmaceuticals, Inc. | e4766132-4faa-4f76-89fe-75d4a6fd737b | 2025-12-29 | Boxed warning, Warnings, Adverse reactions | 1050493 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 97563516-306a-4e17-9690-edbda49ecd83 | Drospiren-Eth estra-Levomefol Ca 3-0.03-0.451 MG (21) Oral Tablet / Levomefol Ca 0.451 MG (7) Oral Tablet 28 Day Pack | PSN | 23 | These highlights do not include all the information needed to use SAFYRAL safely and effectively. See full prescribing information for SAFYRAL. SAFYRAL (drospirenone/ethinyl estradiol/levomefolate calcium tablets and levomefolate calcium tablets) for oral use Initial U.S. Approval: 2010 | 20260304 |
| 97563516-306a-4e17-9690-edbda49ecd83 | {21 (drospirenone 3 MG / ethinyl estradiol 0.03 MG / levomefolate calcium 0.451 MG Oral Tablet) / 7 (levomefolate calcium 0.451 MG Oral Tablet) } Pack | GPCK | 23 | These highlights do not include all the information needed to use SAFYRAL safely and effectively. See full prescribing information for SAFYRAL. SAFYRAL (drospirenone/ethinyl estradiol/levomefolate calcium tablets and levomefolate calcium tablets) for oral use Initial U.S. Approval: 2010 | 20260304 |
| 6928f186-190d-4c40-beab-81cf80cd45cb | {21 (drospirenone 3 MG / ethinyl estradiol 0.03 MG / levomefolate calcium 0.451 MG Oral Tablet) / 7 (levomefolate calcium 0.451 MG Oral Tablet) } Pack | GPCK | 17 | These highlights do not include all the information needed to use DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM TABLETS AND LEVOMEFOLATE CALCIUM TABLETS safely and effectively. See full prescribing information for safely and effectively. See full prescribing information for DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM . DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM TABLETS AND LEVOMEFOLATE CALCIUM TABLETS, for oral use Initial U.S. Approval: 2010 | 20260304 |
| 6928f186-190d-4c40-beab-81cf80cd45cb | Drospiren-Eth estra-Levomefol Ca 3-0.03-0.451 MG (21) Oral Tablet / Levomefol Ca 0.451 MG (7) Oral Tablet 28 Day Pack | PSN | 17 | These highlights do not include all the information needed to use DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM TABLETS AND LEVOMEFOLATE CALCIUM TABLETS safely and effectively. See full prescribing information for safely and effectively. See full prescribing information for DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM . DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM TABLETS AND LEVOMEFOLATE CALCIUM TABLETS, for oral use Initial U.S. Approval: 2010 | 20260304 |
| e4766132-4faa-4f76-89fe-75d4a6fd737b | Drospiren-Eth estra-Levomefol Ca 3-0.03-0.451 MG (21) Oral Tablet / Levomefol Ca 0.451 MG (7) Oral Tablet 28 Day Pack | PSN | 8 | These highlights do not include all the information needed to use TYDEMY TM safely and effectively. See full prescribing information for TYDEMY TM . TYDEMY TM (drospirenone, ethinyl estradiol and levomefolate calcium tablets and levomefolate calcium tablets), for oral use Initial U.S. Approval: 2010 | 20251229 |
| e4766132-4faa-4f76-89fe-75d4a6fd737b | {21 (drospirenone 3 MG / ethinyl estradiol 0.03 MG / levomefolate calcium 0.451 MG Oral Tablet) / 7 (levomefolate calcium 0.451 MG Oral Tablet) } Pack | GPCK | 8 | These highlights do not include all the information needed to use TYDEMY TM safely and effectively. See full prescribing information for TYDEMY TM . TYDEMY TM (drospirenone, ethinyl estradiol and levomefolate calcium tablets and levomefolate calcium tablets), for oral use Initial U.S. Approval: 2010 | 20251229 |